Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1994-05-31
1997-10-28
Kight, John
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 47, 536 267, 536 2763, 536 2762, 536 2623, 536 2626, A61K 3170
Patent
active
056818319
ABSTRACT:
Pharmaceutical formulations of compounds and drugs for treatment against viruses and prions (proteinaceous infectious particles), e.g., CMV, Herpes Simplex, Hepatitis B, Scapie Creutzfeldt-Jakob Disease, in particular for drug treatment of persons and animals suffering from certain retroviral infections, and of person suffering from infection by retroviruses related to human immuno-deficiency viruses (HIV), and for prophylactic drug treatment of persons who may be suffering from such infections. The anti-viral pharmaceutical formulations according to the invention have the general formula: ##STR1##
REFERENCES:
patent: 3666856 (1972-05-01), Elion et al.
patent: 3758684 (1973-09-01), Elion et al
patent: 3851056 (1974-11-01), Stork et al.
patent: 3966916 (1976-06-01), Kampe et al.
patent: 4007186 (1977-02-01), Emanuel
patent: 4016262 (1977-04-01), Fauland et al.
patent: 4464361 (1984-08-01), Ohki et al.
patent: 4558051 (1985-12-01), Sunshine
patent: 4605644 (1986-08-01), Foker
patent: 4657897 (1987-04-01), Bristol et al.
patent: 4687733 (1987-08-01), Trewyn et al.
patent: 4791103 (1988-12-01), Trivedi et al.
patent: 4843066 (1989-06-01), Yamada et al.
patent: 5292725 (1994-03-01), Prendergast
Burrows et al., "The Isolation and Identification of Two Cytokinins from Escherichia coli Transfer Ribonucleic Acids," Biochemistry, 8 (7), 307 1-3076 (1969).
Woodsworth et al., "Characterization of Monoclonal Antibodies Specific for Isopentenyl Adenosine Derivatives Occurring in Transfer RNA," Biochem. Biophys, Res. Comm., 114(2), 791-796 (1983).
Hecht et al., "Cytokinins: Influence of Side-Chain Planarity on N.sup.6 -Substituted Adenines and Adenosines on Their Activity in Promoting Cell Growth," Phytochemistry, 9, 1907-1913 (1970).
Shaw et al., "Purine, Pyrimidines, and Imidazoles. Part XXIV. Synthesis of Zeatin, a Naturally Occurring Adenine Derivative with Plant Cell-division-promoting Activity, and Its 9-.beta.-D-Ribofuranoside," J. Chem. Soc,, Part C, 1966.921-924.
Burrows et al., "Cytokinin from Soluble RNA of Escherichia coli: 6-(3-Methyl-2-butenylamino)-2-methylthio-9-.beta.-D-ribofuranosylpurine," Science, 161, 691-693 (1968).
Vold et al., "Urine Levels of -(.DELTA..sup.2 -Isopentenyl)adenosine, and 2'-O-Methylguanosine as Determined by Radioimmunoassay for Normal Subjects and Cancer Patients," Cancer Research, 42. 5265-5269 (1982).
Bratslavskaya et al., "Study of the Mechanism of Inhibition of Moloney's Mouse Sarcoma Virus by N.sup.6 -(.DELTA..sup.2 -Isopentenyl)-adenosine," Onkornavirusy i Nesoetsifich. Rezistentnost 0rganizma, 1978, 29-33; Chem/ Abstr., 90(11), p. 34, Abstr. No. 80810k (1979).
Gallo et al., "N.sup.6 -(.DELTA..sup.2 -Isopentenyl) Adenosine: The Regulatory Effects of a Cytokinin and Modified Nucleoside from t-RNA on Human Lymphocytes," Biochimica et Biophysica Acta. 281, 488-500 (1972).
Milo et al., "Effect of Cytokinins on Tobacco Mosaic Virus Production in Local-Lesion and Systemic Hosts," Virology, 38, 26-31 (1969).
Brown, "Survivors Offer Lessons in Resisting HIV--Key to `Non-Progression` May Be Within Individuals," New York Times, Aug. 10, 1994, p. A3.
The Merck Index, "An Encyclopedia of Chemicals and Drugs", Ninth Edition, No. 141 (p. 20), No. 4791 (p. 648), No. 9538 (p. 1267).
Brazilian Journal of Medical and Biological Research, vol. 20, No. 1, 1987, pp. 1-10; R.C. Guimaraes et al.: "Purine base uptake in Trypanosoma cruzi: adaptations and effects of inhibitors".
Experimental Parasitology, Vol. 66, No-2, Aug. 1988, pp. 189-196; D.R. Taylor et al.: "Leishmania mexicana amazonensis: ADP-ribosyltransferase antagonists specifically inhibit promastigote differentiation".
Experimental Parasitology, vol. 56, No. 3, Dec. 1983, pp. 409-415; G.T. Williams: "Trypanosoma cruzi: inhibition".
T. Roosevelt: "The synthesis and some properties of polynucleotides containing N6-(.DELTA.-2-isopentenyl)-adenosine".
Biochemistry International, vol. 9, No. 2, Aug. 1984, pp. 207-218; L.L. Nolan et al.: "The effect of formycin B on mRNA translation and uptake of purine precursors in Leishmania mexicana".
Experimental Parasitology, vol. 56, No. 2, Oct. 1983, pp. 236-240; J.L. Avila et al.: "Trypanosoma cruzi: 4-aminopyrazolopyrimmide in the treatment of experimental chagas'disease".
Journal of Heterocyclic Chemistry, vol. 20, No. 2, Mar.-Apr. 1983, pp. 295-299; M.P. Lamontagne et al.: "Preparation of 7-substituted pyrrolo(2,3-d)pyrimidines and 9-substituted purines as potential antiparasitic agents".
The Journal of Immunology, vol. 129, No. 6, Dec. 1982, pp. 2759-2762; J.J. Wirth et al.: "Inhibitory action of elevated levels of adenosine-3':5' cyclic monophosphate on phagocytosis: effects on macrophage-Trypanosoma cruzi interaction".
International Journal of Pharmaceutics, vol. 65, Nos. 1-2, 1990, pp. 57-62; B. Chaudhuri et al.: "Polyether polyurethane delivery systems. II: Effect of coadministration of pentostatin with N6-(.DELTA.-2-isopentenyl) adenosine".
Windholz et al. (eds.), Merck Index, 10th Ed., Merck & Co., Rahway, NJ, 1983, pp. 22-23, See Entry No. 142.
R. Thedford, "The Synthesis and Some Properties of Polynucleotides Containing N.sup.6 -(.DELTA.-2-isopentenyl)-adenosine," Diss. Abstr. Int. B, 34(2), 528-529 (1973).
Kampe et al., "Coronary Dilating N.sup.6 -Benzyladenosines," Patent No. 2,007,273 (W. Ger.), Aug. 26, 1971; Chem. Abstr., 75. p. 347, Abstr. No. 141121a (1971); only Abstract supplied.
R. S. Root-Bernstein(I), "AIDS IS More Than HIV: Part I," Genetic Engineering News, Sep 1, 1992, pp. 4-6.
R. S. Root-Bernstein(II), "AIDS IS More Than HIV: Part II," Genetic Engineering News, Sep 15, 1992, pp. 4-5.
Crane L. Eric
Kight John
LandOfFree
Method of treating viral and retroviral infections including HIV does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating viral and retroviral infections including HIV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating viral and retroviral infections including HIV will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1026207